Understanding Compulsivity in OCD Through Brain Imaging and Therapy

October 21, 2025 updated by: Amy Rapp, Icahn School of Medicine at Mount Sinai

This important clinical study explores how the brain processes compulsive behaviors in people with Obsessive Compulsive Disorder (OCD) using advanced EEG technology and specialized therapy. The research team at Icahn School of Medicine aims to better understand the neurocognitive components behind compulsions, which could lead to more effective treatments for this challenging condition.

The study compares two groups of participants: adults diagnosed with OCD who will receive Exposure and Response Prevention (EX/RP) therapy, and healthy volunteers without psychiatric conditions. All participants must be right-handed English speakers between 18-55 years old.

Key aspects of the research include:

  • 17 therapy sessions over 10 weeks for OCD participants
  • Comprehensive assessments using multiple psychological scales
  • EEG measurements to study brain activity patterns
  • Detailed tracking of symptoms throughout treatment

The primary treatment, EX/RP therapy, is considered the gold-standard behavioral treatment for OCD. It works by gradually exposing patients to anxiety-provoking thoughts or situations while helping them resist compulsive behaviors. Researchers will measure outcomes using several well-validated tools including the Yale Brown Obsessive Compulsive Scale and Obsessive Compulsive Inventory-Revised.

For caregivers and patients considering participation, it's important to note that this study includes careful screening processes to ensure safety. The exclusion criteria help maintain research integrity while protecting participants' wellbeing. Those currently taking psychiatric medications or with certain co-occurring conditions may not be eligible.

This research holds significant promise for advancing our understanding of OCD. By combining cutting-edge neuroscience with behavioral therapy, scientists hope to identify specific brain patterns associated with compulsive behaviors. Such discoveries could eventually lead to more personalized treatment approaches and better outcomes for people living with OCD.

The study represents an important collaboration between Icahn School of Medicine and the National Institute of Mental Health, reflecting the growing recognition of OCD as a serious mental health condition requiring innovative research approaches. While OCD affects about 1-2% of the population, its impact on daily functioning can be severe, making studies like this particularly valuable.

For those struggling with OCD, participation in research like this offers not only potential personal benefit through access to specialized therapy, but also the opportunity to contribute to scientific knowledge that may help future patients. The inclusion of healthy volunteers is equally important, as their data provides crucial comparison points for understanding how OCD affects brain function.

As with any clinical trial, participants should carefully consider the time commitment and requirements before enrolling. However, the potential benefits - both individual and collective - make this an important option for those seeking to better understand or overcome OCD symptoms. The study's combination of therapy and neuroscience represents an exciting frontier in mental health research.

Upcoming Clinical Trials

Subscribe